Host T-Cells Contribute to Immune Reconstitution and Improved Outcome in Recipients of CD34 Selected T-Cell Depleted Allografts (TCD HCT) with Full Hematopoietic Cell but Persistent Mixed T-Cell Chimerism | Zendy

Richard J. O’Reilly | Zendy; Guenther Koehne | Zendy; Glenn Heller | Zendy; Farid Boulad | Zendy; Hugo CastroMalaspina | Zendy; Sergio Giralt | Zendy; Ann A. Jakubowski | Zendy; Nancy A. Kernan | Zendy; Esperanza B. Papadopoulos | Zendy; MiguelAngel Perales | Zendy; Susan E. Prockop | Zendy; Marcel R.M. van den Brink | Zendy; James W. Young | Zendy; Susan H. Hsu | Zendy

Open Access

Host T-Cells Contribute to Immune Reconstitution and Improved Outcome in Recipients of CD34 Selected T-Cell Depleted Allografts (TCD HCT) with Full Hematopoietic Cell but Persistent Mixed T-Cell Chimerism

Author(s) -

Richard J. O’Reilly,

Guenther Koehne,

Glenn Heller,

Farid Boulad,

Hugo CastroMalaspina,

Sergio Giralt,

Ann A. Jakubowski,

Nancy A. Kernan,

Esperanza B. Papadopoulos,

MiguelAngel Perales,

Susan E. Prockop,

Marcel R.M. van den Brink,

James W. Young,

Susan H. Hsu

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.408

Subject(s) - medicine , melphalan , thiotepa , fludarabine , myeloid , cd34 , leukapheresis , immunology , cyclophosphamide , transplantation , haematopoiesis , oncology , stem cell , chemotherapy , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research